Login / Signup

In silico bioprospecting of taraxerol as a main protease inhibitor of SARS-CoV-2 to develop therapy against COVID-19.

Somdutt MujwarRanjit K Harwansh
Published in: Structural chemistry (2022)
The online version contains supplementary material available at 10.1007/s11224-022-01943-x.
Keyphrases
  • sars cov
  • respiratory syndrome coronavirus
  • coronavirus disease
  • molecular docking
  • social media
  • health information
  • psychometric properties
  • healthcare
  • stem cells
  • mesenchymal stem cells
  • bone marrow